ENTITY

BrightGene Bio-Medical Technology (688166 CH)

Analysis

Health Care • China

BrightGene Bio-Medical Technology Co., Ltd. researches, develops, manufactures, and distributes biopharmaceuticals. The Company produces antifungal drugs, cardiovascular drugs, iron supplement agents, and more. BrightGene Bio-Medical Technology sells its products in Israel, USA, Japan, India, South Korea, and other countries and regions.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00